Keywords: Biotechnology stocsk, IPO, Burrill, Trius Thera, NuPathe, Amyris, Partnering, Financing, USA

US Biotech posts strong third quarter 2010 performance as capital markets go on a tear, says Burrill & Co

Article | 06 October 2010

Print This

Biotech posted its strongest monthly and quarterly performance in several years in what was hailed as the strongest September rally ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in